| IPO Company Profile © ipodata.com |
| Message Board | SEC Filings | Peer IPO Companies |
| OMP, Inc. |
| 310 Golden Shore, Long Beach, CA 90802 * (562) 100-1007 |
| Business Description | The company is a leading specialty pharmaceutical company that develops, markets and sells products for physician-mediated skin health and restoration. |
|
Filing Information Not yet | |||
| To Trade As | OMPI (NASNTL) | Industry | Pharmaceutical (SIC 2834) |
| Type of Stock Offered | Common Shares | Filing Date | 11/17/2000 |
| Domestic Shares Filed | 4,500,000 | Filing Range | $14.00 - $16.00 |
| Foreign Shares Filed | 0 | Offering Amount | $67,500,000 |
| Company Shares | 4,500,000 | Est. Expenses | - - |
| Selling Shrhldrs Shares | 0 | Post-IPO Shares | - - |
| Primary Underwriting Group | ||
| Underwriter Name | Participation | Underwriter Phone |
| CIBC World Markets | Lead Manager | (212) 667-7400 |
| Prudential Vector Healthcare | Co-manager | (800) 546-1231 |
| Income Statement and Cash Flow Summary | |||||||
| Prior Audited Income |
Latest Unaudited Income | ||||||
| Full Year Audited Figures | 9 Months Ending | ||||||
| Figures in U.S. millions except per share data | 12/31/1997 | 12/31/1998 | 12/31/1999 | 9/30/1999 | 9/30/2000 | ||
| Revenues | - | - | 11.506 | 17.017 | 23.076 | 16.256 | 24.983 |
| Income from Oper. | - | - | 0.652 | -0.209 | 2.984 | 2.069 | 0.245 |
| Net Income | - | - | 0.581 | -0.590 | 3.405 | 2.440 | -0.439 |
| E.P.S | - | - | - | - | - | - | - |
| Revenue Growth (%) | - | - | 47.90 | 35.606 | 53.68 | ||
| Net Income Growth (%) | - | - | - | - | - | ||
| Oper. Profit Margin (%) | - | - | 5.67 | - | 12.93 | 0.98 | 12.73 |
| Net Profit Margin (%) | - | - | 5.05 | - | 14.76 | - | 15.01 |
| Cash Flow - Oper. | 1.35 | 1.25 | -2.01 | ||||
| Cash Flow - Inv. | -0.75 | -0.48 | -1.76 | ||||
| Cash Flow - Fin. | -1.22 | -0.69 | 3.41 | ||||
| Balance Sheet Summary and Financial Ratios | |||||
| Balance sheet as of: 9/30/2000 | Financial Ratios | ||||
| Total Assets | 30.52 | Current Assets | 10.34 | Current Ratio | 1.17 |
| Total Liab. | 31.94 | Current Liab. | 8.83 | Debt Ratio | 104.64% |
| Total Equity | -1.42 | Working Cap. | 1.51 | Debt to Equity Ratio | - |
| Cash | 0.29 | Return on Assets | 11.16% | ||
| Use Of Proceeds |
The proceeds from the proposed offering will be used to redeem preferred stock, to increase sales and marketing efforts; to fund potential acquisitions; to invest in strategic collaborations and to fund working capital and other general corporate purposes. |
| Legal Counsel Registrar Auditor | |
| Issuer's Law Firm | Michael, Best & Friedrich |
| Bank's Law Firm | Shearman & Sterling |
| Registrar/Transfer Agent | Firstar Bank Milwaukee, N.A. |
| Send us feedback if you would like to request that we hyperlink a firm on this page | |
| Principal Shareholders | ||
| Name of Shareholder | % Owned Before | % Owned After |
| Mandarin Partners LLC | 74.80 | |
| Note: represents ownership of 5% or more prior to the offering. | ||